Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Cognitive Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Early research (Phase 1)Study completedNCT01716637
What this trial is testing

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Life Extension Foundation Inc. 12
Not applicableStudy completedNCT04884529
What this trial is testing

Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial

Who this might be right for
DementiaMild Cognitive Impairment
Lady Davis Institute 30
Not applicableStudy completedNCT02660437
What this trial is testing

PCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Schön Klinik Berchtesgadener Land 91
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Not applicableStudy completedNCT00611533
What this trial is testing

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

Who this might be right for
MenopauseCognitive Disturbances
University of Pennsylvania 16
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Not applicableStudy completedNCT01937221
What this trial is testing

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentMild to Moderate Cognitive Impairment
Duke University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07058688
What this trial is testing

NTRX-07 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc. 48
Not applicableLooking for participantsNCT07284446
What this trial is testing

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

Who this might be right for
Congestive Heart Failure ChronicCognitive Impairment, MildDepressive Symptoms Mild to Moderate in Severity
Lithuanian University of Health Sciences 300
Large-scale testing (Phase 3)Looking for participantsNCT06976216
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Not applicableNot Yet RecruitingNCT07773493
What this trial is testing

A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement

Who this might be right for
Memory DisordersMild Cognitive ImpairmentDementia+2 more
University of Minnesota 200
Not applicableStudy completedNCT05433493
What this trial is testing

Effect of Individual Cognitive Stimulation on Memory and Executive Function in Older Adults With Alzheimer's Disease

Who this might be right for
DementiaNeurocognitive DisordersCognitive Impairment+2 more
Rsocialform - Geriatria, Lda 142
Not applicableUnknownNCT02778581
What this trial is testing

Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment

Who this might be right for
Cognitive ImpairmentsAlzheimer Disease
Team Foods Colombia S.A. 110
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Not applicableStudy completedNCT03536975
What this trial is testing

Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers

Who this might be right for
Cognitive Impairment, MildDementia, Mild
University Hospital, Rouen 48
Next Page